|
Greetings,
On Oct. 19, 2022, the CDC’s Director signed a decision allowing Novavax monovalent COVID-19 boosters for adults.
This action authorizes the use of the Novavax COVID-19 Vaccine, Adjuvanted as a first booster dose (0.5 mL) to the following individuals at least six months after completion of a primary vaccination with an authorized or approved COVID-19 vaccine:
- Individuals 18 years of age and older for whom an FDA-authorized mRNA bivalent COVID-19 booster vaccine is not accessible or clinically appropriate, and
- Individuals 18 years of age and older who elect to receive the Novavax COVID-19 Vaccine, Adjuvanted because they would otherwise not receive a booster dose of a COVID-19 vaccine.
For more information, please review the following links:
CDC Updated Information: Novavax Booster for Adults 18+
FDA EUA Letter: https://www.fda.gov/media/159902/download
Updated Novavax EUA Fact Sheet for Providers
Updated Novavax EUA Fact Sheet for Recipeints and Caregivers
If you have any question, please reach out to Immunize@health.ok.gov.
Thank you,
Immunization Service | Oklahoma State Department of Health |
